Browsing by Author "Ramos, S."
Now showing 1 - 4 of 4
Results Per Page
Sort Options
- Opsoclonus myoclonus syndrome: how long are we going to go on researching?]Publication . Ramos, S.; Temudo, T.Rev Neurol. 2002 Aug 16-31;35(4):322-5. [Opsoclonus myoclonus syndrome: how long are we going to go on researching?] [Article in Spanish] Ramos S, Temudo T. Interna complementar de Pediatria. Serviço de Pediatria. Hospital Geral de Santo Antonio, Porto, Portugal. teresatemudo@netcabo.pt Abstract INTRODUCTION: Opsoclonus myoclonus is a rare neurological syndrome affecting children and adults, and which is characterised by a sudden onset of chaotic eye movements and myoclonias. In children it generally appears before the age of three as a parainfectious or paraneoplasic process; the type of tumour most frequently associated with this syndrome is the neuroblastoma. CASE REPORT: We report the case of a 22 month old girl who, after a febrile syndrome probably caused by a virus, began to present myoclonias in the upper and lower limbs, opsoclonus, a marked ataxic gait and extreme irritability. After ruling out neoplasia, oral corticotherapy was started and the neurological picture gradually improved. CONCLUSION: By reporting this clinical picture, our intention is to make the particular aspects of this neurological condition known, and highlight the need for neoplasias to be detected in time and for early treatment in order to prevent sequelae, especially when it appears as a paraneoplasic syndrome. PMID: 12235560 [PubMed - indexed for MEDLINE]
- Position statement on bioresorbable vascular scaffolds in PortugalPublication . Teles, R.; Pereira, H.; Cyrne-Carvalho, H.; Patrício, L.; Santos, R.; Baptista, J.; Pipa, J.; Farto-Abreu, P.; Faria, H.; Ramos, S.; Gama-Ribeiro, V.; Martins, D.; Almeida, M.BACKGROUND: Bioresorbable vascular scaffolds (BVS) were recently approved for percutaneous coronary intervention in Europe. The aim of this position statement is to review the information and studies on available BVS, to stimulate discussion on their use and to propose guidelines for this treatment option in Portugal. METHODS AND RESULTS: A working group was set up to reach a consensus based on current evidence, discussion of clinical case models and individual experience. The evidence suggests that currently available BVS can produce physiological and clinical improvements in selected patients. There are encouraging data on their durability and long-term safety. Initial indications were grouped into three categories: (a) consensual and appropriate - young patients, diabetic patients, left anterior descending artery, long lesions, diffuse disease, and hybrid strategy; (b) less consensual but possible - small collateral branches, stabilized acute coronary syndromes; and (c) inappropriate - left main disease, tortuosity, severe calcification. CONCLUSION: BVS are a viable treatment option based on the encouraging evidence of their applicability and physiological and clinical results. They should be used in appropriate indications and will require technical adaptations. Outcome monitoring and evaluation is essential to avoid inappropriate use. It is recommended that medical societies produce clinical guidelines based on high-quality registries as soon as possible.
- Thrombus aspiration in patients with ST-elevation myocardial infarction: results of a national registry of interventional cardiologyPublication . Pereira, H.; Caldeira, D.; Teles, R.; Costa, M.; Silva, P.; Ribeiro, V.; Brandão, V.; Martins, D.; Matias, F.; Pereira-Machado, F.; Baptista, J.; Abreu, P.; Santos, R.; Drummond, A.; Carvalho, H.; Calisto, J.; Silva, J.; Pipa, J.; Marques, J.; Sousa, P.; Fernandes, R.; Ferreira, R.; Ramos, S.; Oliveira, E.; Almeida, M.BACKGROUND: We aimed to evaluate the impact of thrombus aspiration (TA) during primary percutaneous coronary intervention (P-PCI) in 'real-world' settings. METHODS: We performed a retrospective study, using data from the National Registry of Interventional Cardiology (RNCI 2006-2012, Portugal) with ST-elevation myocardial infarction (STEMI) patients treated with P-PCI. The primary outcome, in-hospital mortality, was analysed through adjusted odds ratio (aOR) and 95% confidence intervals (95%CI). RESULTS: We assessed data for 9458 STEMI patients that undergone P-PCI (35% treated with TA). The risk of in-hospital mortality with TA (aOR 0.93, 95%CI:0.54-1.60) was not significantly decreased. After matching patients through the propensity score, TA reduced significantly the risk of in-hospital mortality (OR 0.58, 95%CI:0.35-0.98; 3500 patients). CONCLUSIONS: The whole cohort data does not support the routine use of TA in P-PCI, but the results of the propensity-score matched cohort suggests that the use of selective TA may improve the short-term risks of STEMI.
- Tuberculose miliar no século XXI – a propósito de um caso clínicoPublication . Pinho, L.; Oliveira, S.; Serino, J.; Febra, T.; Ramos, S.; Silva, C.; Dinis, M.Introdução: Atualmente, a tuberculose ainda representa um sério problema de saúde pública. A idade precoce e a infeção VIH constituem importantes fatores de risco para doença grave ou disseminada. Caso clínico: Apresentamos o caso de uma menina de três anos de idade observada por febre prolongada sem foco infecioso evidente ao exame físico. O estudo analítico inicial foi sugestivo de infeção urinária, pelo que iniciou antibioticoterapia empírica. A urocultura confirmou esse diagnóstico, mas a febre persistiu. Na investigação complementar, a radiografia torácica revelou um infiltrado pulmonar com padrão miliar. O Mycobacterium tuberculosis foi isolado no aspirado gástrico, líquor e urina. Iniciou tratamento com antituberculosos e corticóide, com melhoria clínica significativa. Conclusões: Nesta era de tecnologia médica avançada, a tuberculose ainda é um desafio diagnóstico, especialmente quando a apresentação clínica é atípica e extrapulmonar. Um elevado índice de suspeição clínica é fundamental, pois a instituição precoce do tratamento é decisiva para o prognóstico.